Introduction
============

Inflammatory diseases alter the pharmacokinetics and pharmacodynamics of various drugs, resulting in their decreased clinical effects and increased adverse effects ([@b32-jir_1_41]; [@b31-jir_1_41]; [@b1-jir_1_41]). Such an inflammation-induced alteration is well known especially in dental anesthesia. Local anesthetic failure or difficulty to obtain satisfactory analgesia commonly occurs in the situations of pulpitis and apical periodontitis ([@b18-jir_1_41]). The anesthetic efficacies of lidocaine and mepivacaine injections are remarkably affected in the teeth with irreversible pulpitis ([@b10-jir_1_41]; [@b29-jir_1_41]). The presence of pulpitis has been estimated to cause inferior alveolar nerve block to fail in approximately 30%--45% of cases ([@b4-jir_1_41]; [@b25-jir_1_41]). Although a variety of mechanistic hypotheses were proposed for explaining the decreased effects of local anesthetics in the presence of inflammation, the most cited is the theory that the acidosis of inflamed tissues reduces the anesthetic potencies of administered drugs ([@b20-jir_1_41]; [@b2-jir_1_41]).

Since clinically used local anesthetics are structurally the tertiary amines with aromatic rings, they exist as charged and uncharged molecules with the relative amounts depending on their medium pH and pKa values. While both species are relevant to pharmacological activities, local anesthetics diffuse in uncharged form through nerve sheaths and penetrate into cell membranes to reach the cytoplasmic binding sites or receptors on transmembrane channels. In addition to the blockade of voltage-gated sodium channels, the mode of action of anesthesia includes the drug and membrane lipid interaction which induces the changes in membrane physicochemical property, fluidization or disordering ([@b16-jir_1_41]; [@b12-jir_1_41]). These pharmacological features, together with a correlation between anesthetic potency and lipid solubility ([@b6-jir_1_41]), strongly suggest that the drugs interact with membrane lipid bilayers to induce local anesthesia. Lactic acid and acidic by-products are increasingly produced and concentrated in and near inflamed tissues, causing the acidosis which lowers the tissue pH at least the order of 0.5--1.0 pH unit ([@b26-jir_1_41]; [@b7-jir_1_41]). The pKa values of almost local anesthetics in clinical use are larger than 7.5 ([@b16-jir_1_41]). According to the Henderson-Hasselbalch equation (Log~10~ \[uncharged drug\]/\[charged drug\] = pH − pKa), a greater proportion of administered drugs should be the charged molecules with much less membrane interactivity and permeability under acidic conditions corresponding to inflamed tissues. Therefore, local anesthetic effects would be decreased in the presence of inflammation, leading to the hypothetic mechanism based on tissue acidosis. This hypothesis seems to be so theoretical and understandable that it has been conventionally accepted despite being not experimentally confirmed.

The hydrophobic interaction underlies the effects of local anesthetics on lipid bilayers ([@b23-jir_1_41]; [@b12-jir_1_41]; [@b37-jir_1_41]). However, the drug action on biomembranes is not identical to that speculated from the organic: aqueous phase partition. Unlike experimental membrane specimens with the simple lipid composition, nerve cell membranes consist of different phospholipid and sterol components ([@b36-jir_1_41]). Their compositional variations greatly affect the membrane interactivities of drugs ([@b38-jir_1_41]).

Therefore, we attempted to verify the conventional acidosis mechanism for the local anesthetic failure associated with inflammation. We comparatively studied the interactions of local anesthetics with membrane lipids by lowering the reaction pH and varying the membrane lipid composition. Of particular interest were whether local anesthetics could change membrane fluidity at acidic pH by interacting with lipid bilayers and whether any of lipid components were specifically responsible for the possible membrane interaction. For this purpose, we used the liposome system in which reaction conditions and membrane lipids were readily manipulated to examine the influence of pH and the importance of individual lipids ([@b3-jir_1_41]). Based on the verification results, we propose an alternative hypothesis which was speculated from the potential reactivity of peroxynitrite pathologically relevant to inflammation.

Materials and methods
=====================

Reagents
--------

Lidocaine, prilocaine and bupivacaine, all in hydrochloride salt form, were purchased from Sigma (St. Louis, MO, USA), and 1,2-dipalmitoylphosphatidylcholine (DPPC), 1-palmitoyl-2-oleoylphosphatidylcholine (POPC), 1-palmitoyl-2-oleoylphosphatidylethanolamine (POPE), 1-palmitoyl-2-oleoylphosphatidylserine (POPS) and sphingomyelin (SM) from Avanti Polar Lipids (Alabaster, AL, USA). Cholesterol, 1,6-diphenyl-1,3,5-hexatriene (DPH) and peroxynitrite were obtained from Wako Pure Chemicals (Osaka, Japan), Molecular Probes (Eugene, OR, USA) and Dojindo (Kumamoto, Japan), respectively. The concentration of peroxynitrite was spectrophotometrically determined according to manufacturer's directions, and then diluted to be 10 mM with 0.1 M NaOH. The prepared peroxynitrite solutions were stored at −80 ºC and consumed within three weeks after preparation. Water of liquid chromatographic grade (Kishida, Osaka, Japan) and dimethyl sulfoxide of spectroscopic grade (Kishida) were used for preparing reagent solutions. All other chemicals were of the highest grade available commercially.

Liposome preparation
--------------------

DPH-labeled liposomes of the lipid bilayer structure (total lipids of 0.14 mM) were prepared by hydrating the lipid dry film with 20 mM sodium phosphate buffer of pH 7.4 and 6.4 (Wako Pure Chemicals) containing 100 mM KCl as reported previously ([@b37-jir_1_41]). The molar ratio of DPH to membrane lipids was adjusted to be 1 : 200. The lipid composition of liposomal membranes was as follows: DPPC (100 mol%), POPC and cholesterol (55 : 45, mol%), POPE and cholesterol (55 : 45, mol%), POPS and cholesterol (55 : 45, mol%), and SM and cholesterol (55 : 45, mol%). Nerve cell model membranes were prepared with POPC, POPE, POPS, SM and cholesterol (11 : 16.5 : 11 : 16.5 : 45, mol%) according to the composition of major membrane lipids of peripheral nerve cells ([@b36-jir_1_41]).

Membrane lipid interaction
--------------------------

Local anesthetics dissolved in dimethyl sulfoxide (20 μL) were added to the liposome preparations (3.98 mL) of pH 7.4 and 6.4 so that a final concentration was 0.2% (w/v) for lidocaine, 0.2% (w/v) for prilocaine and 0.05% (w/v) for bupivacaine. The concentration of dimethyl sulfoxide was adjusted to be less than 0.5% (v/v) of the total volume so as not to influence the membrane fluidity of liposomes. After reaction for 15 min at 37 ºC, DPH fluorescence polarization was measured by an RF-540 spectrofluorometer (Shimadzu, Kyoto, Japan) equipped with a polarizer and a cuvette thermo-controller as reported previously ([@b39-jir_1_41]). Compared with control values (dimethyl sulfoxide vehicle added), the decrease of DPH polarization means the increase of fluidity (membrane fluidization) in the hydrocarbon cores of lipid bilayers, reflecting the acting site of tested drugs ([@b21-jir_1_41]). The potencies to interact with liposomal membranes were compared on the basis of the changing degree of polarization values relative to controls.

Peroxynitrite treatment
-----------------------

Local anesthetics dissolved in dimethyl sulfoxide (20 μL) were added to the nerve cell model membrane preparations (3.93 mL) of pH 7.4 and 6.4 to be a final concentration of 0.2% (w/v) for lidocaine, 0.2% (w/v) for prilocaine and 0.05% (w/v) for bupivacaine. Immediately after that, peroxynitrite in 0.1 M NaOH (50 μL) was added to be 50 μM with vortex-mixing for 5 sec, followed by reaction for 15 min at 37 ºC to induce the membrane effects of local anesthetics. The corresponding volume of 0.1 M NaOH vehicle was added to controls. Thereafter, DPH polarization was measured as described above. The influence of peroxynitrite was evaluated by comparing the membrane-fluidizing effects of local anesthetics treated with and without peroxynitrite.

Statistical analysis
--------------------

Results are expressed as mean ± SE (N = 6--8). Data were statistically analyzed by Student's *t*-test (StatView 5.0; SAS Institute, Cary, NC, USA). A P value \<0.05 was considered significant.

Results
=======

Lidocaine, prilocaine and bupivacaine acted on DPPC liposomal membranes at pH 7.4 to increase their fluidity as shown by DPH polarization decreases ([Figure 1](#f1-jir_1_41){ref-type="fig"}). At pH 6.4, however, their membrane-fluidizing effects were significantly weakened. Compared with pH 7.4, the decreasing values of polarization were reduced to 30.8 ± 1.2% for lidocaine, 32.5 ± 0.9% for prilocaine and 32.5 ± 0.5% for bupivacaine.

Even if the pH was lowered from 7.4 to 6.4, local anesthetics more greatly fluidized nerve cell model membranes compared with DPPC liposomal membranes ([Figure 2](#f2-jir_1_41){ref-type="fig"}). While the polarization decreasing values at pH 6.4 relative to pH 7.4 were 69.6 ± 2.1% for lidocaine, 70.5 ± 1.9% for prilocaine and 71.8 ± 2.9% for bupivacaine, their potencies to interact with nerve cell model membranes at pH 6.4 were 2.2--2.3 times those with DPPC liposomal membranes.

The effects of pH lowering remarkably depended on the kind of membrane component phospholipids. The membrane-interactive potencies of lidocaine, prilocaine and bupivacaine were greatly diminished at pH 6.4 in POPC, POPE and SM liposomal membranes ([Figure 3](#f3-jir_1_41){ref-type="fig"}). However, all the tested anesthetics fluidized POPS liposomal membranes at pH 6.4 with almost the same potency as that at pH 7.4.

The relative potencies of local anesthetics to interact with liposomal membranes at pH 6.4 to pH 7.4 are shown in [Table 1](#t1-jir_1_41){ref-type="table"}, together with the relative concentrations of uncharged molecules which were calculated by the Henderson-Hasselbalch equation using the pKa values of 7.9 for lidocaine, 7.8 for prilocaine and 8.1 for bupivacaine ([@b5-jir_1_41]).

The fluidizing effects of lidocaine, prilocaine and bupivacaine on nerve cell model membranes were inhibited by treating with peroxynitrite ([Figure 4](#f4-jir_1_41){ref-type="fig"}). The inhibition occurred at both pH 7.4 and pH 6.4, which showed no differences in inhibition potency.

Discussion
==========

Representative anesthetics lidocaine, prilocaine and bupivacaine were subjected to the membrane interactions at clinically used concentrations ([@b16-jir_1_41]). All of them fluidized DPPC liposomal membranes in 15 min, being consistent with their onset time ([@b40-jir_1_41]; [@b35-jir_1_41]). However, their membrane-interactive potencies were significantly decreased at pH 6.4 which is almost comparable to inflamed tissue conditions ([@b26-jir_1_41]). Such pH-dependence may provide experimental support for the conventional mechanism based on tissue acidosis.

Local anesthetics must traverse ensheathing perineuria which are hydrophobic (lipoid) barriers against the drugs to reach nerve fibers. They also must penetrate into or across neuronal cell membranes consisting of lipid bilayers to exert their pharmacological activities. When blocking voltage-gated sodium channels, local anesthetics also permeate cell membranes to bind to the receptors. Inflammation causes metabolic acidosis which lowers the pH of affected tissues ([@b26-jir_1_41]; [@b7-jir_1_41]). Such inflammatory conditions would alter the pharmacokinetics and pharmacodynamics of local anesthetics by reducing their interactivities with lipid bilayers and/or membrane lipids.

There is a systematic relationship between anesthetic potency and hydrophobicity to determine the membrane interactivity ([@b5-jir_1_41]). The hydrophobicity of local anesthetics is characterized by their partition coefficients, usually in an octanol:buffer system ([@b34-jir_1_41]). While tertiary amine local anesthetics exist in uncharged (free base) or charged form depending on their pKa values and medium pH, the uncharged molecules are much more membrane-interactive than the charged ones. As shown in [Table 1](#t1-jir_1_41){ref-type="table"}, the relative potencies to interact with DPPC liposomal membranes decrease in all the tested drugs by lowering the pH from 7.4 to 6.4, which is correlated to the decreasing relative concentrations of uncharged molecules.

The effects of lidocaine, prilocaine and bupivacaine on nerve cell model membranes at pH 6.4 were much greater than presumed from their relative concentrations of uncharged molecules ([Table 1](#t1-jir_1_41){ref-type="table"}). Although the rank order is different between relative potency and concentration, this is interpretable by the difference in hydrophobicity of local anesthetics. The hydrophobic interaction with phosphatidylcholine membranes is estimated to be prilocaine \< lidocaine \< bupivacaine in increasing order of intensity based on their chromatographic behaviors in the reversed-phase partition system ([@b37-jir_1_41]). The partition coefficients are greatest in the order of prilocaine \< lidocaine \<\< bupivacaine for both uncharged and charged molecules ([@b34-jir_1_41]). The results of nerve cell model membranes never support the acidosis mechanism, indicating that the tissue acidification is not essentially responsible for the decreased effects of local anesthetics in the presence of inflammation.

Unlike DPPC liposomal membranes consisting of phosphatidylcholine alone, nerve cell model membranes were prepared with different phospholipids (POPC, POPE, POPS and SM) and cholesterol to resemble peripheral nerve cells ([@b36-jir_1_41]). Such lipid composition may explain why local anesthetics are able to interact with membrane lipids under inflammatory acidic conditions. As well as DPPC liposomes, liposomal membranes consisting of POPC, POPE and SM showed much less fluidization at pH 6.4 compared with pH 7.4. However, only POPS liposomal membranes were significantly fluidized even at pH 6.4 by lidocaine, prilocaine and bupivacaine despite that their charged molecules predominated. With respect to structural difference of these phospholipids, DPPC, POPC, POPE and SM are zwitterionic, whereas POPS is acidic. Positively charged (cationic) drugs show much higher affinity to acidic (anionic) phospholipids like POPS compared with zwitterionic ones ([@b8-jir_1_41]; [@b38-jir_1_41]). Not only uncharged but also charged anesthetics are able to interact with lipid bilayers, the former deeply in the hydrophobic core, but the latter in the head-group regions of phospholipids ([@b24-jir_1_41]). Local anesthetics in charged form electrostatically interact with the negatively charged sites in membranes at pH lower than the pKa values and their adsorbed amounts depend on the membrane surface charge ([@b23-jir_1_41]). In this study, local anesthetics with pKa over 7.8 showed less fluidizing effects on DPPC, POPC, POPE and SM liposomal membranes at pH 6.4 as the uncharged molecules decreased. On the other hand, their effects on POPS liposomal membranes were significantly great even at pH 6.4, contradicting to the relative decrease of uncharged molecules, but correlating to the relative increase of charged molecules. As known in certain amphiphilic drugs ([@b33-jir_1_41]), the cationic moieties of local anesthetics possibly pair with the anionic head-groups of acidic phospholipids to form the seemingly uncharged ion-pairs, which could penetrate into lipid bilayers and modify membrane fluidity. Acidic phosphatidylserine is referred to as a counter-ion to pair with positively charged anesthetics.

Local anesthetics have been verified to interact with nerve cell membranes at the pH corresponding to inflammatory acidosis. Tissues can buffer the excess acidity ([@b42-jir_1_41]) and such buffering is more potent in inflamed tissues ([@b27-jir_1_41]). These pathophysiological features are also unfavorable to the conventional mechanism based on tissue acidosis, requiring an alternative theory for the local anesthetic failure associated with inflammation.

Inflammatory cells produce peroxynitrite ([@b30-jir_1_41]), which has been implicated in the pathogenesis of various diseases including inflammation ([@b9-jir_1_41]). Inflamed tissues are characterized by the production of nitric oxide and superoxide anion which react to form peroxynitrite. Inflammatory diseases influence the effects of different drugs due to the formation of nitric oxide ([@b19-jir_1_41]; [@b17-jir_1_41]). Several local anesthetics, including lidocaine and bupivacaine, react with peroxynitrite ([@b13-jir_1_41]; [@b14-jir_1_41]). Peroxynitrite is also able to inhibit Na^+^/K^+^-ATPase activity through the modification of membrane fluidity ([@b22-jir_1_41]). Therefore, our hypothesis is that inflammatory peroxynitrite may interact with local anesthetics to affect their membrane interactivities.

In the membrane interaction experiments, peroxynitrite has been revealed to inhibit the anesthetic-induced fluidization of nerve cell model membranes. The reactivity of peroxynitrite is greater at acidic to neutral pH than at alkaline pH ([@b28-jir_1_41]). While local anesthetics were reacted with 50 μM peroxynitrite for 5 sec at pH 7.4 and 6.4, these experimental conditions are not in conflict with the peroxynitrite exposure by activated inflammatory cells ([@b15-jir_1_41]).

Since venules and capillaries are dilated in inflamed tissues, the increased blood flow due to vasodilatation would promote the absorption and removal of local anesthetics from their administered sites ([@b27-jir_1_41]; [@b16-jir_1_41]). The presence of inflammation modifies the activities of sensory nerves and ion channels to possibly induce afferent hyperexcitability and hyperalgesia ([@b11-jir_1_41]; [@b41-jir_1_41]). In addition to these pathophysiological changes, it is hypothesized that inflammatory peroxynitrite could participate in the decrease of local anesthetic effects.

In conclusion, inflammatory acidosis is not as important for the decreased efficacy of local anesthesia as recognized conventionally. As a novel mechanistic hypothesis, peroxynitrite relevant to inflammation may interact with local anesthetics to modify their pharmacological activities.
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![Effects of local anesthetics on DPPC liposomal membranes at different pH. Lidocaine (0.2%, w/v), prilocaine (0.2%, w/v) and bupivacaine (0.05%, w/v) were reacted with DPPC liposomes for 15 min at 37 ºC at pH 7.4 and 6.4, followed by DPH fluorescence polarization measurements. Each result represents mean ± SE (N = 6--8). ^\*\*^p \<0.01, compared with pH 7.4.](jir_1_41f1){#f1-jir_1_41}

![Effects of local anesthetics on nerve cell membranes at different pH. Lidocaine (0.2%, w/v), prilocaine (0.2%, w/v) and bupivacaine (0.05%, w/v) were reacted with nerve cell model membranes for 15 min at 37 ºC at pH 7.4 and 6.4, followed by DPH fluorescence polarization measurements. Each result represents mean ± SE (N = 6--8). ^\*\*^p \<0.01, compared with pH 7.4.](jir_1_41f2){#f2-jir_1_41}

![Effects of local anesthetics on liposomal membranes consisting of different phospholipids. Lidocaine (0.2%, w/v), prilocaine (0.2%, w/v) and bupivacaine (0.05%, w/v) were reacted with POPC, POPE, SM or POPS liposomes for 15 min at 37 ºC at pH 7.4 and 6.4, followed by DPH fluorescence polarization measurements. Each result represents mean ± SE (N = 6--8). ^\*\*^p \<0.01, compared with pH 7.4.](jir_1_41f3){#f3-jir_1_41}

![Influence of peroxynitrite on local anesthetic membrane effects. Lidocaine (0.2%, w/v), prilocaine (0.2%, w/v) and bupivacaine (0.05%, w/v) were treated with 50 μM peroxynitrite for 5 sec at pH 7.4 and 6.4. Their effects on nerve cell model membranes were determined after reaction for 15 min at 37 ºC by measuring DPH fluorescence polarization. Each result represents mean ± SE (N = 6--8). ^\*\*^p \< 0.01, compared with control (not treated with peroxynitrite).](jir_1_41f4){#f4-jir_1_41}

###### 

Relative concentrations of uncharged anesthetic molecules calculated by the Henderson-Hasselbalch equation and relative potencies to interact with different liposomal membranes (mean ± SE, N = 6--8)

                              Relative potency to interact with                                                                                                                                                                                                                                                       
  ------------- ----- ------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  Lidocaine     7.4   100.0   100.0 ± 0.2                                             100.0 ± 1.5                                             100.0 ± 2.8                                             100.0 ± 1.8                                             100.0 ± 1.8                                             100.0 ± 1.0
                6.4   12.8    29.8 ± 1.1[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   70.2 ± 2.1[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   36.7 ± 0.8[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   34.1 ± 1.6[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   27.5 ± 0.4[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   98.2 ± 0.7
  Prilocaine    7.4   100.0   100.0 ± 0.7                                             100.0 ± 1.8                                             100.0 ± 1.8                                             100.0 ± 2.4                                             100.0 ± 1.7                                             100.0 ± 0.6
                6.4   13.5    31.5 ± 0.8[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   71.1 ± 1.9[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   38.9 ± 0.9[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   35.5 ± 1.8[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   27.6 ± 0.8[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   94.1 ± 0.9[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}
  Bupivacaine   7.4   100.0   100.0 ± 1.1                                             100.0 ± 1.4                                             100.0 ± 2.3                                             100.0 ± 1.3                                             100.0 ± 2.0                                             100.0 ± 0.6
                6.4   11.8    31.4 ± 0.5[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   72.4 ± 2.9[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   42.1 ± 2.0[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   37.5 ± 1.5[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   27.4 ± 1.1[\*\*](#tfn1-jir_1_41){ref-type="table-fn"}   99.5 ± 0.6

p \< 0.01 compared with pH 7.4.
